neoplasm
|
• only 3% of hemizygous females expressing the transgene in a Sdc1tm1Cma null background develop mammary tumors (median time: ~36 weeks) versus 34% of hemizygous females in a Sdc1 wild-type background (median time: ~21 weeks)
• these Wnt1-induced tumors are predominantly alveolar adenocarcinomas
|
endocrine/exocrine glands
|
|
• hemizygous females expressing the transgene in a Sdc1tm1Cma null background exhibit a ~70% inhibition of Wnt1-induced mammary gland hyperplasia relative to hemizygous females of a Sdc1 wild-type background
|
integument
|
|
• hemizygous females expressing the transgene in a Sdc1tm1Cma null background exhibit a ~70% inhibition of Wnt1-induced mammary gland hyperplasia relative to hemizygous females of a Sdc1 wild-type background
|


Analysis Tools